A series of new 6-substituted-1,3-dimethyl-1H-pyrazolo [3,4-b]pyrazin-5(4H)-ones (13a -e) and 1, 3-dimethyl-5a,6a,7,8-tetrahydro-1H-pyrazolo[4,3-e] N-(1,3-dimethyl-4-nitro-1H pyrazol-5-yl) D,L-α-amino acids 11a -e and 14. The latter compounds underwent reductive lactamization to deliver the corresponding target heterocyclic systems 13a -e and 15.
Introduction
Since the introduction of antipyrine (1) [1] as a derivative of pyrazole in 1884 by Knorr as antipyretic agent, several related derivatives have been synthesized as herbicidal [2] , antineoplastic [3] , antiarrhythmic [4] , antiinflammatory [4] , antischistosomal [5] , and antitumor [6a,b] agents. In recent years, clinically important pyrazoles were also synthesized that exhibit antimicrobial [7] , antifungal [8] , analgesic, antipyretic [9] , ulcerogenic, molluscicidal, and antischistosomal (antibilharzial) [10] activity.
The pyrazole unit is present in a number of natural and synthetic drugs ( Fig. 1 ) with different bioactivities: betazole (2) is bioisosteric with histamine and selectively blocks the H 2 -receptor [1b], celecoxib (3) is a powerful COX-2 inhibitor and exhibits analgesic and antiarthritic effects [11] , while difenamizole (4) is an analgesic, anti-inflammatory, and antipyretic drug [1b] . Isofezolac (5) is a Japanese drug reported to have a good anti-inflammatory activity [9] , and Fenpyroximate (6) is a novel anti-acaricide agent [12] .
Fused pyrazoles have also received considerable attention because of their pharmacological applications as analgesic, anti-inflammatory, antipyretic [13] , and antifungal agents [8a] . For instance, the derivatives of c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com pyrazolo [3,4-b] pyrazines/pyrazinones 7 -9 ( Fig. 1 ) are reported to exhibit antifungal, antiparasitic and antitumor activities [6a, 14] .
Results and Discussion
The preparation of the new pyrazolo-pyrazinones 13a -e and 15 was achieved by utilizing 5-chloro-1,3-dimethyl-4-nitro-1H-pyrazole (10) as starting material and constructing the pyrazinone unit thereupon through two-step conversions as illustrated in Scheme 1. Thus, direct interaction of 10 with the appropriate α-amino acid has been conducted in aqueous ethanol containing sodium hydrogen carbonate (or potassium carbonate) at 70 -80 • C for 2 -5 d. This reaction follows an S N -Ar (addition-elimination) path and is facilitated by the presence of the strong electron-withdrawing nitro group at position 4 [15] the former primary α-amino acids are weaker nitrogen nucleophiles than the secondary α-amino acid (D,Lproline).
Catalytic hydrogenation of 11a -e, using 5 % Pd/C, led to reduction of the nitro to the amino group. It was followed by spontaneous lactamization and air-oxidation of intermediates 12a -e to afford good yields of the respective target products (13a -e; Scheme 1). Likewise, reductive lactamization of 14 afforded the respective tricyclic system 15.
The new compounds 11a -e, 13a -e, 14 and 15 were characterized by elemental analyses, MS, and NMR spectral data. These data, detailed in the Experimental Section, are consistent with the suggested structures. Thus, their MS spectra displayed the correct molecular ions [M] + for which the m/z values are in agreement with those calculated from the respective molecular formulas. 1 H and 13 C signal assignments to the different protons and carbons in the NMR spectra of the new compounds followed from DEPT and 2D (COSY, HMQC, HMBC) experiments which showed correlations that helped in the full assignments.
Experimental Section
D,L-α-Amino acids, 5-chloro-1,3-dimethyl-4-nitro-1H-pyrazole, and 5 % Pd/C, employed in this study, were purchased from Acros and were used as received. Melting points were measured on an SMP2 Stuart apparatus. IR spectra were recorded from KBr discs on a Nicolet-MAGNA-IR-560 spectrophotometer. 1 H and 13 C NMR spectra were obtained with a Bruker DPX-300 ultrashield instrument. Chemical shifts are expressed in ppm with reference to TMS as internal standard. Electron impact mass spectra (EIMS) were measured using a Varian MAT-112S instrument or a Finnigan MAT-312 spectrometer at 70 eV, at an ion source temperature of 200 • C. Elemental analyses were performed on a Euro Vector elemental analyzer, model EA 3000.
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl) α-amino acids 11a -e and 14

General procedure
A well-stirred mixture of the appropriate D,L-α-amino acid (9 mmol), 5-chloro-1,3-dimethyl-4-nitropyrazole (10, 0.53 g, 3 mmol) and sodium hydrogen carbonate (1.5 g, 18 mmol) in aqueous ethanol (140 mL, 1 : 1 v/v) was heated at 70 -80 • C. The reaction mixture slowly developed a lightyellow color. Progress of the reaction was monitored by TLC and was completed within 4 -5 d. The resultant yellow solution was first extracted with dichloromethane (40 mL), and the aqueous layer was separated and acidified with 3N HCl to pH = 6 -7. The precipitated product was collected by suction filtration, washed with water and dried. Compounds 11a -e and 14 were prepared following the above-described general procedure.
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl)glycine (11a)
This compound was prepared from 10 (0.53 g, 3 mmol) and glycine (0.68 g, 9 mmol), m. 
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl) D,L-valine (11c)
This compound was prepared from 10 (0. 
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl) D,L-leucine (11d)
This
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl) D,L-α-phenylalanine (11e)
N-(1,3-Dimethyl-4-nitro-1H-pyrazol-5-yl) D,L-proline (14)
A mixture of 5-chloro-1,3-dimethyl-4-nitro-1H-pyrazole 
1,3-Dimethyl-6-substituted-1H-pyrazolo[3,4-b]pyrazin-5(4H)-ones 13a -e and 15
General procedure
A solution of the appropriate pyrazolo-amino acid 11a -e or 14 in MeOH (∼ 50 mL) was hydrogenated in the presence of 5 % Pd/C (20 -25 % by mass) at 4 bar for 6 d. The catalyst was then filtered off, and the filtrate was concentrated. The solid obtained was purified on silica gel TLC plates with dichloromethane and methanol (8.5/1.5: v/v) as eluent to afford the respective compounds 13a -e and 15. 
1,3-Dimethyl-1H-pyrazolo[3,4-b]pyrazin-5(4H)-one (13a)
6-Isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyrazin-5(4H)-one (13c)
